PMC:7784786 / 3948-4059 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"154","span":{"begin":60,"end":70},"obj":"Chemical"}],"attributes":[{"id":"A154","pred":"tao:has_database_id","subj":"154","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"T-cell activation and proinflammatory cytokines production, itolizumab was included as part of a Cuban expanded"}